Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols
Valeria Caputo(Vita-Salute San Raffaele University), Nicola Clementi(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University), Hamid Hasson(Vita-Salute San Raffaele University), Roberto Burioni(Vita-Salute San Raffaele University), Roberta A. Diotti(Vita-Salute San Raffaele University), Michela Sampaolo(Vita-Salute San Raffaele University), Sabrina Bagaglio(Vita-Salute San Raffaele University), Elena Criscuolo(Vita-Salute San Raffaele University), Matteo Castelli(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Massimo Clementi(Vita-Salute San Raffaele University), Enzo Boeri(National Cancer Institute), Nicasio Mancini(Vita-Salute San Raffaele University)
Cited by 6
Related Papers
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
|Hepatology|1997|178
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions
|Journal of Virology|1993|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168